CV Sciences Inc (CVSI)

[Bud_Fox1]

Assuming the best case scenario: they have patent, they will get clarity on 505b2 and can prove efficacy and bring drug to market. 2016 market for treating smokeless tobacco is $2billion of which chantix (black box warning) had 45% Mkt share or ~700mm in 2015/16 revenue. Currently we trade ~2.5x annual revenue. Assuming we can get at least a third of chantix's business would adjust our capitalization at ~582.7mm @ 89.2mm shares out, PPS = ~6.5

I get it- This takes time and attracting bigger fish requires a little makeup, R/S. The benefit of uplisting and higher pps means the shares of common may be margin eligible- which, if you're savy, means you could use a block of shares as collateral for options trading. For instance, selling S&P 500 futures contracts against a bucket of cash or CVSI stock to generate income to accumulate the stock. Because the stock is not currently marginable, it sits dormant and dosn't increase buying power.